HOW CAN WE ENSURE EQUITABLE ACCESS TO THE COVID-19 VACCINE?
Building Racial Equity into the Drug Development System
![](https://www.i-mak.org/wp-content/uploads/2017/10/Screen-Shot-2017-10-13-at-9.37.49-PM.png)
Measuring the Impact of Medicines Patent Pool Licenses: A Civil Society Assessment
Why UNITAID Matters for People Living with HIV/AIDS, TB and Malaria – Market Impact Report by the Civil Society Delegations Civil Society Assessment Presentation